Kaye Edward M. MD sold STOK
December 5, 2025 · Form 4 insider transaction
Kaye Edward M. MD sold 500 shares of Stoke Therapeutics, Inc. at $31.85 per share, a transaction worth $15.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
500
Price
$31.85
Total value
$15.9K
InsiderKaye Edward M. MD
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 5, 2025
Filing dateDecember 5, 2025
Shares owned after62,554
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.70 to $31.96 per share, inclusive.